Skip to content
10-Q

Quarterly Report

JRSIS HEALTH CARE CORPORATION JRSS

0001213900-24-075805

← back to feed
Filed
Sep 5, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2024 · Jun 30, 2024 84.6M sh
Shares Diluted Q2 2024 · Jun 30, 2024 84.47M sh
Shares Diluted restated Q2 2024 · Jun 30, 2023 76.76M sh
Shares Diluted restated Q2 2024 · Jun 30, 2023 76.76M sh
Shares Outstanding Q2 2024 · Jun 30, 2024 84.6M sh
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$473.8K
Operating Cash Flow restated Q2 2024 · Jun 30, 2023 $511K
Long Term Debt Q2 2024 · Jun 30, 2024 $12.19K
Long Term Debt Q2 2024 · Dec 31, 2023 $24.95K
Short Term Debt Q2 2024 · Jun 30, 2024 $1.36M
Short Term Debt Q2 2024 · Dec 31, 2023 $983.01K
Stockholders Equity Q2 2024 · Jun 30, 2024 −$7.4K
Stockholders Equity Q2 2024 · Dec 31, 2023 −$137.41K
Current Liabilities Q2 2024 · Jun 30, 2024 $2.11M
Current Liabilities Q2 2024 · Dec 31, 2023 $2.28M
Total Liabilities Q2 2024 · Jun 30, 2024 $2.13M
Total Liabilities Q2 2024 · Dec 31, 2023 $2.31M
Current Assets Q2 2024 · Jun 30, 2024 $1.83M
Current Assets Q2 2024 · Dec 31, 2023 $1.83M
Total Assets Q2 2024 · Jun 30, 2024 $2.11M
Total Assets Q2 2024 · Dec 31, 2023 $2.14M
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.00
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.00
Eps Diluted restated Q2 2024 · Jun 30, 2023 −$0.00
Eps Diluted restated Q2 2024 · Jun 30, 2023 −$0.00
Eps Basic Q2 2024 · Jun 30, 2024 −$0.00
Eps Basic Q2 2024 · Jun 30, 2024 −$0.00
Eps Basic restated Q2 2024 · Jun 30, 2023 −$0.00
Eps Basic restated Q2 2024 · Jun 30, 2023 −$0.00
Sga Expense Q2 2024 · Jun 30, 2024 $186.49K
Sga Expense Q2 2024 · Jun 30, 2024 $287.6K
Sga Expense Q2 2024 · Jun 30, 2023 $118.8K
Sga Expense Q2 2024 · Jun 30, 2023 $150.03K
Rd Expense Q2 2024 · Jun 30, 2024 $9.6K
Rd Expense Q2 2024 · Jun 30, 2024 $19.85K
Rd Expense Q2 2024 · Jun 30, 2023 $38.34K
Rd Expense Q2 2024 · Jun 30, 2023 $68.64K
Net Income Q2 2024 · Jun 30, 2024 −$102.44K
Net Income Q2 2024 · Jun 30, 2024 −$247.79K
Net Income restated Q2 2024 · Jun 30, 2023 −$106.02K
Net Income restated Q2 2024 · Jun 30, 2023 −$60.57K
Operating Income Q2 2024 · Jun 30, 2024 −$118.72K
Operating Income Q2 2024 · Jun 30, 2024 −$279.62K
Operating Income restated Q2 2024 · Jun 30, 2023 −$127.28K
Operating Income restated Q2 2024 · Jun 30, 2023 −$49.76K
Gross Profit Q2 2024 · Jun 30, 2024 $186.11K
Gross Profit Q2 2024 · Jun 30, 2024 $243.33K
Gross Profit Q2 2024 · Jun 30, 2023 $39.61K
Gross Profit Q2 2024 · Jun 30, 2023 $191K
Cost Of Revenue Q2 2024 · Jun 30, 2024 $411.28K
Cost Of Revenue Q2 2024 · Jun 30, 2024 $854.48K
Cost Of Revenue Q2 2024 · Jun 30, 2023 $297.78K
Cost Of Revenue Q2 2024 · Jun 30, 2023 $623.39K
Revenue Q2 2024 · Jun 30, 2024 $597.4K
Revenue Q2 2024 · Jun 30, 2024 $1.1M
Revenue restated Q2 2024 · Jun 30, 2023 $337.4K
Revenue restated Q2 2024 · Jun 30, 2023 $814.39K